Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.
Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations.
GlobalData on MSN
FDA clears Varian’s TrueBeam systems for low-dose radiation therapy in osteoarthritis
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients ...
RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...
Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...
MedPage Today on MSN
Medicare Coverage Appears Spotty for Newer Rheumatoid Arthritis Meds
Advantage plans do a better job than standalone Part D policies, albeit with important gap ...
Tom Nolan reviews this week’s research GLP-1 receptor agonists, now widely used for diabetes, cardiovascular disease, and weight loss, seem to be as effective for these indications regardless of age, ...
Up to 30% of children with juvenile arthritis develop uveitis, an eye inflammation that can damage vision. New research highlights immune cells as treatment targets.
Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam, and Edge, have received FDA 510(k) clearance for the use of low-dose ...
A new case study documents six months of complete pain relief in an 80-year-old man with arthritis, achieved without ...
BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug delivery and reducing inflammation.
The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results